Fundraising Fox
/Companies
Sign in

InduPro

Seattle, US · Founded 2022 · 61 employees on LinkedIn · 3 known investors

Find your way into InduPro

Sign up to see every warm intro you have to InduPro

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the InduPro team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

InduPro develops next-generation protein therapeutics by leveraging inherent and induced proximity to modulate disease biology, with a focus on ADCs and T-cell engagers. The company built proprietary platforms — Membrane Interactomics (MInt) for target discovery, ARRIS for proximity modalities using multi-specific antibody technology, and internal antibody discovery and engineering — to identify targets and design therapeutic molecules.

BiotechDeep TechMedical Devices

Founders & leadership

InduPro was founded in 2022 by K. Chris Garcia.

KCK. Chris Garcia
K. Chris GarciaScientific Founder
PRPrakash Raman
Prakash RamanCEO
AJAmanda J. Redig
Amanda J. RedigChief Medical OfficerAmanda J. Redig is a medical oncologist and physician-scientist who has worked across academic and industry settings. She serves as Chief Medical Officer at InduPro, a protein therapeutics company focused on ADCs and T-cell engagers.
SLScott Lesley
Scott LesleyPresident & CSOScott Lesley is President and Chief Scientific Officer of InduPro, which develops protein therapeutics using proximity-modulation approaches for ADCs and T-cell engagers. He has experience in drug discovery and development spanning academic, startup, and large pharmaceutical environments, with expertise in antibody discovery, target validation, and translating research into clinical candidates.
PHPamela Holland
Pamela HollandSVP of BiologyPamela Holland is SVP of Biology at InduPro, where she leads development of protein therapeutics. She brings experience in oncology, immunotherapy, and pre-clinical advancement of cancer therapeutics from basic research into clinical development.
SJSally Johnson
Sally JohnsonChief People OfficerSally Johnson holds certifications in organizational coaching and human resources, with expertise in talent management and leadership development across pharmaceutical and life sciences companies. She has specialized in executive recruitment and business process management for financial services and insurance firms.

Investors · 3

The Column Group✓ confirmed by InduProSan Francisco · $30M

How we know: The Column Group's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us

Vida Ventures✓ confirmed by InduProLos Angeles

How we know: Vida Ventures's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Founder mafia

2 people who came through InduPro went on to found or lead other companies.

Rahul BallalBoard MemberFounded Mediar TherapeuticsPrakash RamanCEOFounded Ribon Therapeutics

Related companies · 2

Aro BiotherapeuticsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Insitroinsitro is a drug discovery and development company that uses machine learning and cellular data to identify therapeutic insights and accelerate the creation of new medicines. The company serves patients and pharmaceutical development by integrating in vitro lab data with human clinical data to decode biology and unlock transformative treatments.

Companies working in the same space as InduPro.

Frequently asked questions

What does InduPro do?
InduPro develops next-generation protein therapeutics by leveraging inherent and induced proximity to modulate disease biology, with a focus on ADCs and T-cell engagers. The company built proprietary platforms — Membrane Interactomics (MInt) for target discovery, ARRIS for proximity modalities using multi-specific antibody technology, and internal antibody discovery and engineering — to identify targets and design therapeutic molecules.
Who founded InduPro?
InduPro was founded by K. Chris Garcia in 2022.
Who are InduPro's investors?
InduPro's investors include MRL Ventures Fund, The Column Group, Vida Ventures.
Where is InduPro headquartered?
InduPro is headquartered in Seattle, US.